Nav

IV Insights Blog

Posts tagged: Global Health

How Ingenuity Is Art: Top Invention Stories from February

In 2002, Mae Jemison, the first African-American woman in space said, “The difference between science and the arts is not that they are different sides of the same coin… they are manifestations of the same thing. The art and sciences are avatars of human creativity.” 

Read full article »

How New Cervical Cancer Screening Technology Could Save the Lives of Hundreds of Thousands of Women

On World Cancer Day, Global Good and QuantuMDx have announced a new partnership to develop a rapid, low-cost and mobile diagnostic test that could make a tremendous difference in the global fight against cervical cancer. 

Read full article »

Our People: Amy Steadman

Amy Steadman is a biochemist for Intellectual Ventures Lab, currently working on a cervical cancer screening project to develop a test that would help diagnose high-risk human papillomavirus (HPV) in the pre-cancer stage. We recently spoke with Amy to learn more about her passion for using research to help women in the developing world, her inspiration for her work and how she rocks out in her free time. 

Read full article »

Patents for Humanity: Global Good’s Passive Vaccine Storage Device, Arktek, wins USPTO Award

Through its Patents for Humanity Award, the United States Patent and Trademark Office (USPTO) illuminates stories of technologies that are making real change in the world for those most in need. This year, one of those stories is ours to tell. 

Read full article »

Nathan Myhrvold at GeekWire Summit 2016

Intellectual Ventures founder and CEO Nathan Myhrvold joined journalists Tom Bishop and Alan Boyle last week for a “fireside chat” at the 2016 GeekWire Summit. The conference brought together more than 800 thought leaders to explore technological advancements and the future of innovation. 

Read full article »

Our People: Adam Akullian

Adam Akullian is a postdoctoral researcher with Intellectual Ventures’ Institute for Disease Modeling (IDM). A National Science Foundation (NSF) Graduate Research Fellowship recipient, Adam is currently focused on mathematical and epidemiological modeling of HIV in sub-Saharan Africa, with the goal of informing effective public health interventions. We met with Adam recently to discuss what brought him to IDM, his hopes for the future, and how collecting snails in China convinced him to pursue a Ph.D. in Epidemiology.  

Read full article »

How Do You Keep Vaccines Cool? (Hint: Look to Space)

The Arktek™, developed by a team at Intellectual Ventures Laboratory, can store a month’s supply of vaccines for a village of 6,000 people in 100 degree plus heat, without electricity. What’s the secret? Vacuum thermal insulation technology – the same technology that has been used to protect spacecraft from temperature extremes while in space and upon re-entry. 

Read full article »

Behind the Breakthrough: Dr. David Bell

This week’s Behind the Breakthrough profiles Dr. David Bell, IV’s Portfolio Lead in Global Health Technology. Dr. Bell is a public health physician with global experience. Born and educated in Australia, he has worked at various organizations in Australia, the United Kingdom, and Europe, including the World Health Organization (WHO) in Geneva, Switzerland. His research experience and interest in technology development gives him a unique understanding of potential solutions for the most pressing public health challenges.  

Read full article »

A World Free of Malaria?

Medical texts from as early as 2700 B.C. include descriptions of malaria—a disease caused by wily parasites transmitted through the bite of a mosquito. Scientists, inventors—even soldiers—have spent centuries searching for remedies and preventions against the disease that today affects nearly 200 million people annually, and is the leading cause of child mortality in the developing world. 

Read full article »

Ebola’s Grim Reminder

Last summer, I watched with the same horror many felt as reports from West Africa emerged of Ebola’s deadly toll. The virus has devastated families, wreaked havoc on health systems and savaged economies. But to be frank, I’m much more worried that next time – and there will be a next time – it will be far worse.

Read full article »

Milestones Met for Vaccine Logistics

2015 brings two early and notable milestones for the Global Good and Intellectual Ventures Laboratory teams’ work to commercialize a passive vaccine storage device: a stamp of approval from the World Health Organization and branding transition to our manufacturing partner in China, AUCMA.

Read full article »

Global Good & GE Partner on Malaria Diagnostics

The key premise behind Global Good’s work is the concept of “catalytic invention.” Based on the idea that the world has the tools and inventiveness needed to solve some of humanity’s toughest problems, much of that potential remains locked behind technology or market barriers. Our focus is on developing inventions that can help address these barriers and catalyze markets that are sustainable for the long term.

Read full article »

A Cool Way to Combat Ebola

Healthcare professionals who are treating Ebola patients protect themselves from virus exposure by wearing Personal Protective Equipment (PPE), including double-layer gloves, coveralls, and boots. Imagine what that must feel like to those who are on the front lines of the Ebola outbreak in West Africa’s hot temperatures. Changing equipment offers brief relief, but it’s a lengthy process and potentially puts workers at risk of infection each time their skin is exposed.

Read full article »

Global Leaders Chart the Future

The Boao Forum for Asia came to North America for the first time this year, and Seattle proudly hosted what’s become a prestigious gathering of the brightest minds in government, business, and academia.

Read full article »

IV Investigates: Research Highlights from IV Lab

If you follow our Insights blog, you’ve read about some important milestones in the invention industry – from new technology development to patent reform. Insights is just one of the ways we participate in the conversation about invention and share information about who we are and what we do.

Read full article »

IV in the News: Institute for Disease Modeling

It’s been a busy couple of months for IV’s Institute for Disease Modeling. By developing detailed computer simulations of disease transmission for malaria, polio, tuberculosis, and HIV overlaid with real-time computer modeling of climate, migration and population shifts, IDM provides the scientific data for local governments, multi-lateral institutions and non-profits to make broad policy, program and funding decisions that will help eradicate deadly diseases.    

Read full article »

IV Lab in 2013

Tucked away behind a suburban strip-mall in Bellevue, WA, more than 150 scientists in fields ranging from computational modeling and electrical engineering to microbiology and physics make up the talented team at the Intellectual Ventures (IV) Lab

Read full article »

Forward-looking Partner in China

As my colleague Yan Sheng highlighted in his recent post, Invention East-West, Chinese companies are quickly catching up with their peer companies around the world. Several Chinese companies are also taking on challenging projects and investing and making long-term commitments in and for the developing world. One such company is AUCMA, one of China's leading refrigeration companies and our partner in the commercialization of Global Good's vaccine storage invention for use in developing countries. 

Read full article »

Hacking With A Conscience

In September, Intellectual Ventures’ resident futurist, inventor, and hacker, Pablos Holman, participated in the Zeitgeist Americas conference, hosted by Google.

Read full article »

Global Good Signs First Commercialization Agreement

Global Good announced today that we have partnered with AUCMA—a leading refrigeration company—to manufacture and distribute our vaccine storage invention in the developing world. This is the first such agreement for Global Good and, as my colleague Geoff Deane notes, this accomplishment marks a significant milestone for a project that began more than four years ago with the goal to help lifesaving vaccines reach children in developing countries. Thanks in large part to those years of dedication and ingenuity at IV Lab, we are now one step closer to realizing that goal.

Read full article »

Why I Went on /.

Yesterday I took part in a live Slashdot Q&A. For those of you who aren’t familiar, Slashdot is a lot like the Roman Forum. Its online citizens are a lively and opinionated group and they don’t shy away from taking on topics, companies or people who intrigue or irritate them. 

Read full article »

Unlocking the Power of Invention for Developing Countries

I was drawn to Global Good by one daunting challenge – to realize the full power of invention in parts of the world that need it most. As an inventor, entrepreneur and executive, I’ve spent my career trying to solve problems and satisfy market needs, but none of this scale and importance. 

Read full article »

Nathan Myhrvold Urges Risk-Taking at 2012 Social Innovation Fast Pitch (VIDEO)

Nathan Myhrvold, CEO and co-founder of IV, recently delivered the keynote address at the 2012 Social Innovation Fast Pitch in Seattle. Created by Social Venture Partners, the Social Innovation Fast Pitch offers coaching, mentoring and workshops for local innovators to hone their ideas, culminating in a series of competitive rounds that provide recognition and awards for the winners.

Read full article »

IV Collaborates on New Pelvic Fracture Surgery with Top Canadian Research Organizations

Around this time last year I was involved in a serious motorcycle accident that left me in the hospital with multiple broken bones, including a severely fractured pelvis. I was lucky to have one of the world’s best surgeons treat my injuries, spent long hours in rehabilitation, and fortunately recovered from  the accident much faster than initially expected. Regrettably, many others who suffer this injury are not so lucky—the mortality rate associated with severe pelvic fractures can be as high as 60%.

Read full article »

IV Speaks: Fall 2012

Interested in hearing more from IV this fall? IV’s founders, executives, and employees at every level regularly speak at public events and seminars. Here’s a snapshot of upcoming opportunities:  

Read full article »

News You Can Use

For April’s News You Can Use, we are sharing some inspirational stories and updates on innovation, science and the job market for engineers. Check back each month to get caught up on all the latest trends and news within the industry.

Read full article »

Optimism and Urgency at Gates Foundation’s Malaria Forum

Largely an afterthought in most parts of the world, malaria still claims nearly one million victims each year – most of them children. IV CEO and co-founder Nathan Myhrvold joined a panel of experts at the Bill & Melinda Gates Foundation’s Malaria Forum last week to discuss the role epidemiological modeling can play in understanding and controlling this deadly disease. IV’s modeling work was also featured in Bill Gates’ keynote as one tool in the path forward toward malaria eradication. 

Read full article »

Categories

Archives

Twitter Follow us on Twiter!

#DYK home design = a multibillion dollar industry? Introducing ISF Incubator spinout LexSet, which helps retailers… twitter.com/i/web/status/9…

Nov 21

It's difficult to ensure that grants & charity funds get into the right hands. Our spinout @sunlightpayment is work… twitter.com/i/web/status/9…

Nov 20

It turns out that fertilizers don't always work the way they should to help improve crops. Researchers at IV are he… twitter.com/i/web/status/9…

Nov 19